Intech Investment Management »

Iovance Biotherapeutics shares owned by Intech Investment Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Intech Investment Management from 13F filings

Historical chart of Intech Investment Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Intech Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Intech Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $920k 98k 9.39

More positions owned by Intech Investment Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
UnitedHealth (UNH)
Progressive Corporation (PGR)
Chipotle Mexican Grill (CMG)
Wal-Mart Stores (WMT)
Constellation Energy (CEG)
Netflix (NFLX)
Hca Holdings (HCA)

View all positions for Intech Investment Management

Top funds holding Iovance Biotherapeutics

Perceptive Advisors
Vanguard Group
MHR Fund Management
BlackRock
BlackRock
State Street Corporation
Soleus Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Artisan Partners Limited Partnership
Balyasny Asset Management
Long Focus Capital Management
Principal Financial Group
T. Rowe Price Associates
Palo Alto Investors

View all funds holding Iovance Biotherapeutics